Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Equillium	ContraFect	ProPhase Labs	Leap Therapeutics	Oramed Pharmaceuticals
Symbol	NASDAQ:EQ	NASDAQ:CFRX	NASDAQ:PRPH	NASDAQ:LPTX	NASDAQ:ORMP
Price Information
Current Price	$7.05	$5.25	$7.66	$2.33	$8.91
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.9	1.4	1.1	1.5	1.3
Analysis Score	3.5	3.5	3.5	3.5	3.5
Community Score	4.4	2.6	2.2	2.6	3.1
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	0.8	0.0	0.8	0.0
Earnings & Valuation Score	0.6	0.0	0.0	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$14.00	$16.33	$25.00	$5.13	$13.33
% Upside from Price Target	98.58% upside	211.11% upside	226.37% upside	119.96% upside	49.64% upside
Trade Information
Market Cap	$174.52 million	$146.00 million	$116.08 million	$139.00 million	$261.69 million
Beta	1.71	1.08	0.24	1.35	1.98
Average Volume	641,711	239,008	270,629	882,068	752,550
Sales & Book Value
Annual Revenue	N/A	N/A	$9.88 million	N/A	$2.71 million
Price / Sales	N/A	N/A	11.75	N/A	96.56
Cashflow	N/A	$0.63 per share	N/A	N/A	N/A
Price / Cash	N/A	8.39	N/A	N/A	N/A
Book Value	$2.40 per share	$1.01 per share	$0.97 per share	($0.07) per share	$1.40 per share
Price / Book	N/A	N/A	7.90	N/A	6.36
Profitability
Net Income	$-25,600,000.00	$-12,790,000.00	$-3,150,000.00	$-32,900,000.00	$-11,510,000.00
EPS	($1.47)	$1.11	N/A	($1.47)	($0.56)
Trailing P/E Ratio	N/A	N/A	0.00	N/A	N/A
Forward P/E Ratio	N/A	N/A	∞	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	-12.92%	N/A	-424.76%
Return on Equity (ROE)	-60.79%	-38.08%	-15.95%	-89.24%	-45.93%
Return on Assets (ROA)	-47.03%	-11.44%	-11.65%	-70.07%	-30.33%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.12%	N/A	0.93%	N/A	N/A
Current Ratio	17.91%	11.61%	8.35%	8.70%	8.93%
Quick Ratio	17.91%	11.61%	7.35%	8.70%	8.93%
Ownership Information
Institutional Ownership Percentage	31.14%	56.43%	3.92%	41.90%	6.03%
Insider Ownership Percentage	52.30%	3.70%	29.20%	25.89%	16.10%
Miscellaneous
Employees	26	24	48	24	N/A
Shares Outstanding	24.75 million	27.81 million	15.15 million	59.66 million	29.37 million
Next Earnings Date	3/25/2021 (Estimated)	3/17/2021 (Estimated)	3/24/2021 (Estimated)	3/15/2021 (Estimated)	4/5/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources